Literature DB >> 27528516

Mini-Exome Coupled to Read-Depth Based Copy Number Variation Analysis in Patients with Inherited Ataxias.

Cecilia Marelli1, Claire Guissart2, Cecile Hubsch3, Mathilde Renaud4, Jean-Philippe Villemin2, Lise Larrieu2, Perrine Charles5, Xavier Ayrignac1, Sabrina Sacconi6, Patrick Collignon7, Danielle Cuntz-Shadfar1,8, Laurine Perrin9, Anelia Benarrosh10, Adrian Degardin11, Ouhaïd Lagha-Boukbiza4, Eugenie Mutez12, Bertrand Carlander1, Raul Juntas Morales1, Victoria Gonzalez1, Clarisse Carra-Dalliere1, Souhayla Azakri1, Claude Mignard13, Elisabeth Ollagnon14, Nicolas Pageot1, Dominique Chretien15, Christian Geny1, Jean-Philippe Azulay16, Christine Tranchant4, Mireille Claustres2, Pierre Labauge1, Mathieu Anheim4, Cyril Goizet17, Patrick Calvas18, Michel Koenig2.   

Abstract

Next-generation sequencing (NGS) has an established diagnostic value for inherited ataxia. However, the need of a rigorous process of analysis and validation remains challenging. Moreover, copy number variations (CNV) or dynamic expansions of repeated sequence are classically considered not adequately detected by exome sequencing technique. We applied a strategy of mini-exome coupled to read-depth based CNV analysis to a series of 33 patients with probable inherited ataxia and onset <50 years. The mini-exome consisted of the capture of 4,813 genes having associated clinical phenotypes. Pathogenic variants were found in 42% and variants of uncertain significance in 24% of the patients. These results are comparable to those from whole exome sequencing and better than previous targeted NGS studies. CNV and dynamic expansions of repeated CAG sequence were identified in three patients. We identified both atypical presentation of known ataxia genes (ATM, NPC1) and mutations in genes very rarely associated with ataxia (ERCC4, HSD17B4). We show that mini-exome bioinformatics data analysis allows the identification of CNV and dynamic expansions of repeated sequence. Our study confirms the diagnostic value of the proposed genetic analysis strategy. We also provide an algorithm for the multidisciplinary process of analysis, interpretation, and validation of NGS data.
© 2016 WILEY PERIODICALS, INC.

Entities:  

Keywords:  ataxia; copy number variations; exome sequencing; mini-exome; molecular diagnosis; trinucleotide repeat expansion

Mesh:

Substances:

Year:  2016        PMID: 27528516     DOI: 10.1002/humu.23063

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  12 in total

Review 1.  Clinical application of next generation sequencing in hereditary spinocerebellar ataxia: increasing the diagnostic yield and broadening the ataxia-spasticity spectrum. A retrospective analysis.

Authors:  Daniele Galatolo; Alessandra Tessa; Alessandro Filla; Filippo M Santorelli
Journal:  Neurogenetics       Date:  2017-12-06       Impact factor: 2.660

Review 2.  The clinical utility of exome and genome sequencing across clinical indications: a systematic review.

Authors:  Salma Shickh; Chloe Mighton; Elizabeth Uleryk; Petros Pechlivanoglou; Yvonne Bombard
Journal:  Hum Genet       Date:  2021-08-08       Impact factor: 4.132

3.  ATP8A2-related disorders as recessive cerebellar ataxia.

Authors:  Claire Guissart; Alexander N Harrison; Mehdi Benkirane; Ibrahim Oncel; Elif Acar Arslan; Anna K Chassevent; Kristin Baraῆano; Lise Larrieu; Maria Iascone; Romano Tenconi; Mireille Claustres; Nesibe Eroglu-Ertugrul; Patrick Calvas; Haluk Topaloglu; Robert S Molday; Michel Koenig
Journal:  J Neurol       Date:  2019-10-14       Impact factor: 4.849

4.  The need to develop a patient-centered precision medicine model for adults with chronic disability.

Authors:  Susan M Wolf; Bharat Thyagarajan; Brent L Fogel
Journal:  Expert Rev Mol Diagn       Date:  2017-04-03       Impact factor: 5.225

5.  Efficacy of Exome-Targeted Capture Sequencing to Detect Mutations in Known Cerebellar Ataxia Genes.

Authors:  Marie Coutelier; Monia B Hammer; Giovanni Stevanin; Marie-Lorraine Monin; Claire-Sophie Davoine; Fanny Mochel; Pierre Labauge; Claire Ewenczyk; Jinhui Ding; J Raphael Gibbs; Didier Hannequin; Judith Melki; Annick Toutain; Vincent Laugel; Sylvie Forlani; Perrine Charles; Emmanuel Broussolle; Stéphane Thobois; Alexandra Afenjar; Mathieu Anheim; Patrick Calvas; Giovanni Castelnovo; Thomas de Broucker; Marie Vidailhet; Antoine Moulignier; Robert T Ghnassia; Chantal Tallaksen; Cyril Mignot; Cyril Goizet; Isabelle Le Ber; Elisabeth Ollagnon-Roman; Jean Pouget; Alexis Brice; Andrew Singleton; Alexandra Durr
Journal:  JAMA Neurol       Date:  2018-05-01       Impact factor: 18.302

6.  Cerebellar ataxia-dominant phenotype in patients with ERCC4 mutations.

Authors:  Hiroshi Doi; Shigeru Koyano; Satoko Miyatake; Shinji Nakajima; Yuka Nakazawa; Misako Kunii; Atsuko Tomita-Katsumoto; Kayoko Oda; Yukie Yamaguchi; Ryoko Fukai; Shingo Ikeda; Rumiko Kato; Katsuhisa Ogata; Shun Kubota; Noriko Hayashi; Keita Takahashi; Mikiko Tada; Kenichi Tanaka; Mitsuko Nakashima; Yoshinori Tsurusaki; Noriko Miyake; Hirotomo Saitsu; Tomoo Ogi; Michiko Aihara; Hideyuki Takeuchi; Naomichi Matsumoto; Fumiaki Tanaka
Journal:  J Hum Genet       Date:  2018-02-05       Impact factor: 3.172

7.  High rate of hypomorphic variants as the cause of inherited ataxia and related diseases: study of a cohort of 366 families.

Authors:  Mehdi Benkirane; Cecilia Marelli; Claire Guissart; Agathe Roubertie; Elizabeth Ollagnon; Ariane Choumert; Frédérique Fluchère; Fabienne Ory Magne; Yosra Halleb; Mathilde Renaud; Lise Larrieu; David Baux; Olivier Patat; Idriss Bousquet; Jean-Marie Ravel; Danielle Cuntz-Shadfar; Catherine Sarret; Xavier Ayrignac; Anne Rolland; Raoul Morales; Morgane Pointaux; Cathy Lieutard-Haag; Brice Laurens; Caroline Tillikete; Emilien Bernard; Martial Mallaret; Clarisse Carra-Dallière; Christine Tranchant; Pierre Meyer; Lena Damaj; Laurent Pasquier; Cecile Acquaviva; Annabelle Chaussenot; Bertrand Isidor; Karine Nguyen; William Camu; Alexandre Eusebio; Nicolas Carrière; Audrey Riquet; Eric Thouvenot; Victoria Gonzales; Emilie Carme; Shahram Attarian; Sylvie Odent; Anna Castrioto; Claire Ewenczyk; Perrine Charles; Laurent Kremer; Samira Sissaoui; Nadia Bahi-Buisson; Elsa Kaphan; Adrian Degardin; Bérénice Doray; Sophie Julia; Ganaëlle Remerand; Valerie Fraix; Lydia Abou Haidar; Leila Lazaro; Vincent Laugel; Frederic Villega; Cyril Charlin; Solène Frismand; Marinha Costa Moreira; Tatiana Witjas; Christine Francannet; Ulrike Walther-Louvier; Mélanie Fradin; Brigitte Chabrol; Joel Fluss; Eric Bieth; Giovanni Castelnovo; Sylvain Vergnet; Isabelle Meunier; Alain Verloes; Elise Brischoux-Boucher; Christine Coubes; David Geneviève; Nicolas Lebouc; Jean Phillipe Azulay; Mathieu Anheim; Cyril Goizet; François Rivier; Pierre Labauge; Patrick Calvas; Michel Koenig
Journal:  Genet Med       Date:  2021-07-07       Impact factor: 8.822

8.  A diagnostic ceiling for exome sequencing in cerebellar ataxia and related neurological disorders.

Authors:  Kathie J Ngo; Jessica E Rexach; Hane Lee; Lauren E Petty; Susan Perlman; Juliana M Valera; Joshua L Deignan; Yuanming Mao; Mamdouh Aker; Jennifer E Posey; Shalini N Jhangiani; Zeynep H Coban-Akdemir; Eric Boerwinkle; Donna Muzny; Alexandra B Nelson; Sharon Hassin-Baer; Gemma Poke; Katherine Neas; Michael D Geschwind; Wayne W Grody; Richard Gibbs; Daniel H Geschwind; James R Lupski; Jennifer E Below; Stanley F Nelson; Brent L Fogel
Journal:  Hum Mutat       Date:  2019-11-25       Impact factor: 4.700

9.  A new approach based on targeted pooled DNA sequencing identifies novel mutations in patients with Inherited Retinal Dystrophies.

Authors:  Maitane Ezquerra-Inchausti; Ander Anasagasti; Olatz Barandika; Gonzaga Garay-Aramburu; Marta Galdós; Adolfo López de Munain; Cristina Irigoyen; Javier Ruiz-Ederra
Journal:  Sci Rep       Date:  2018-10-18       Impact factor: 4.379

Review 10.  Recommendations for patient screening in ultra-rare inherited metabolic diseases: what have we learned from Niemann-Pick disease type C?

Authors:  María-Jesús Sobrido; Peter Bauer; Tom de Koning; Thomas Klopstock; Yann Nadjar; Marc C Patterson; Matthis Synofzik; Chris J Hendriksz
Journal:  Orphanet J Rare Dis       Date:  2019-01-21       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.